Suppr超能文献

DROSHA基因中的复发性体细胞突变会诱导肾母细胞瘤中的微小RNA谱发生变化。

Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour.

作者信息

Torrezan Giovana T, Ferreira Elisa N, Nakahata Adriana M, Barros Bruna D F, Castro Mayra T M, Correa Bruna R, Krepischi Ana C V, Olivieri Eloisa H R, Cunha Isabela W, Tabori Uri, Grundy Paul E, Costa Cecilia M L, de Camargo Beatriz, Galante Pedro A F, Carraro Dirce M

机构信息

1] Genomics and Molecular Biology Laboratory, International Research Center, A. C. Camargo Cancer Center, São Paulo, S.P., 01508-010, Brazil [2].

Genomics and Molecular Biology Laboratory, International Research Center, A. C. Camargo Cancer Center, São Paulo, S.P., 01508-010, Brazil.

出版信息

Nat Commun. 2014 Jun 9;5:4039. doi: 10.1038/ncomms5039.

Abstract

Wilms tumour (WT) is an embryonal kidney neoplasia for which very few driver genes have been identified. Here we identify DROSHA mutations in 12% of WT samples (26/222) using whole-exome sequencing and targeted sequencing of 10 microRNA (miRNA)-processing genes. A recurrent mutation (E1147K) affecting a metal-binding residue of the RNase IIIb domain is detected in 81% of the DROSHA-mutated tumours. In addition, we identify non-recurrent mutations in other genes of this pathway (DGCR8, DICER1, XPO5 and TARBP2). By assessing the miRNA expression pattern of the DROSHA-E1147K-mutated tumours and cell lines expressing this mutation, we determine that this variant leads to a predominant downregulation of a subset of miRNAs. We confirm that the downregulation occurs exclusively in mature miRNAs and not in primary miRNA transcripts, suggesting that the DROSHA E1147K mutation affects processing of primary miRNAs. Our data underscore the pivotal role of the miRNA biogenesis pathway in WT tumorigenesis, particularly the major miRNA-processing gene DROSHA.

摘要

肾母细胞瘤(WT)是一种胚胎性肾肿瘤,目前已鉴定出的驱动基因非常少。在此,我们通过对10个微小RNA(miRNA)加工基因进行全外显子测序和靶向测序,在12%的WT样本(26/222)中鉴定出了DROSHA突变。在81%的DROSHA突变肿瘤中检测到一种影响RNase IIIb结构域金属结合残基的复发性突变(E1147K)。此外,我们还在该通路的其他基因(DGCR8、DICER1、XPO5和TARBP2)中鉴定出了非复发性突变。通过评估DROSHA-E1147K突变肿瘤和表达该突变的细胞系的miRNA表达模式,我们确定该变体导致了一部分miRNA的主要下调。我们证实这种下调仅发生在成熟miRNA中,而不是在初级miRNA转录本中,这表明DROSHA E1147K突变影响初级miRNA的加工。我们的数据强调了miRNA生物合成通路在WT肿瘤发生中的关键作用,特别是主要的miRNA加工基因DROSHA。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c80/4062040/7db811307bcc/ncomms5039-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验